Skip to main content
SpringerLink
Log in

Pharmacokinetic Interactions of the Macrolide Antibiotics

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The macrolide antibiotics erythromycin and triacetyloleandomycin (troleandomycin) are prescribed for many types of infections. As such they are often added to other preexisting drug therapy. Thus, there are frequent opportunities for the interaction of these antibiotics with other drugs.

Both erythromycin and triacetyloleandomycin appear to have the potential to inhibit drug metabolism in the liver and also drug metabolism by micro-organisms in the gut, either through their antibiotic effect or through complex formation and inactivation of microsomal drug oxidising enzymes. Of the two agents, triacetyloleandomycin appears to be the more potent inhibitor of microsomal drug metabolism. Published studies indicate that triacetyloleandomycin can significantly decrease the metabolism of methylprednisolone, theophylline and carbamazepine. Its ability to cause ergotism in patients receiving ergot alkaloids and cholestatic jaundice in patients on oral contraceptives may also be related to its inhibitory effect on drug metabolism.

Erythromycin appears to be a much weaker inhibitor of drug metabolism. There are numerous reports describing apparent interactions of erythromycin with theophylline and a lesser number of reports dealing with carbamazepine, warfarin methylprednisolone and digoxin. There are sufficient data to suggest that erythromycin can, in some individuals, inhibit the elimination of methylprednisolone, theophylline, carbamazepine and warfarin. The mean change in drug clearance is about 20 to 25% in most cases, with some patients having a much larger change than others. Like tetracycline, erythromycin also appears to have the potential for increasing the bioavailability of digoxin in patients who excrete high amounts of reduced digoxin metabolites, apparently through destruction of the gut flora that form these compounds.

Concurrent administration of triacetyloleandomycin with drugs whose metabolism is known to be affected or that could potentially be affected should be avoided unless appropriate adjustments in dosage are made. Coadministration of erythromycin with drugs believed to interact should be undertaken with caution and with appropriate patient monitoring.

Among the other macrolide antibiotics, josamycin has seldom been involved in causing drug interactions, while midecamycin and the older derivative spiramycin have not so far been incriminated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albin, H.; Vinçon, G.; Pehourcq, F. and Dangoumeau, J.: Influence de la josamycine sur la pharmacocinetique de la carbamazepine. Therapie 37: 151–156 (1982).

    PubMed  CAS  Google Scholar 

  • Bachmann, K.; Schwartz, J.I.; Forney, R.; Frogameni, A. and Jauregui, L.E.: The effect of erythromycin on the disposition kinetics of warfarin. Pharmacology 28: 171–176 (1984).

    Article  PubMed  CAS  Google Scholar 

  • Bacourt, F. and Couffinhal, J.C.: Ischemic des membres par association dihydroergotamine-triacetyloleandomycin. (Correspondence). Nouvelle Presse Medicale 7: 1956 (1978).

    Google Scholar 

  • Bartle, W.R.: Possible warfarin-erythromycin interaction. (Correspondence). Archives of Internal Medicine 140: 985–987 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Belgian Center for Drug Supervision: Levertoxiciteit van troleandomycin en oestrogenen. Folia Pharmaceutica (Brussels) 6: 64 (1979).

    Google Scholar 

  • Bonfils, C.; Dalet-Beluche, I. and Maurel, P.: Cytochrome P-450 isozyme LM3b from rabbit liver microsomes. Induction of tri-acetyloleandomycin purification and characterization. Journal of Biological Chemistry 258: 5358–5362 (1983).

    PubMed  CAS  Google Scholar 

  • Bonfils, C.; Dalet-Beluche, I. and Maurel, P.: Induction by tri-acetyloleandomycin and partial purification of a LM3 form of cytochrome P-450 from rabbit liver microsomes. Biochemical and Biophysical Research Communications 104: 1011–1017 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Branigan, T.A.; Robbins, R.A.; Cady, W.J.; Nickols, J.G. and Ueda, C.T.: The effects of erythromycin on the absorption and disposition of kinetics of theophylline. European Journal of Clinical Pharmacology 21: 115–120 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brazier, J.L.; Kofman, J.; Faucon, G.; Perin-Fayolle, M.; Lepape, A. and Lanoue, R.: Retard d’élimination de la theophylline du à la troléandomycine. Absence d’effet de la josamycine. Therapie 35: 545–549 (1980).

    PubMed  CAS  Google Scholar 

  • Caldwell, J.H. and Cline, C.T.: Biliary excretion of digoxin in man. Clinical Pharmacology and Therapeutics 19: 410–415 (1976).

    PubMed  CAS  Google Scholar 

  • Claudel, S.; Euvrard, P.; Borx, R.; Chavaillon, A. and Paliard, P.: Cholestase intrahepatique apres association triacetyloleando-mycine-estroprogestatif. Nouvelle Presse Medicale 8: 1182–1183 (1979).

    PubMed  CAS  Google Scholar 

  • Chang, D.C.; Lauer, B.A.; Bell, T.D. and Chair, H.: Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1: 1132–1133 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Cummins, L.H.; Kozak Jr, P.P. and Gillman, S.A.: Erythromycin’s effect on theophylline blood levels. Correspondence. Pediatrics 59: 144–145 (1977).

    Google Scholar 

  • Danan, G.; Descatoire, V. and Pessayre, D.: Self-induction of erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Journal of Pharmacology and Experimental Therapeutics 218: 509–514 (1981).

    PubMed  CAS  Google Scholar 

  • DeLaforge, M.; Jaouen, M. and Mansuy, D.: Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes. A structure-activity relationship. Biochemical Pharmacology 32: 2309–2318 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Derrick Jr, C.W. and Reilly, K.M.: Erythromycin, lincomycin, and clindamycin. Pediatric Clinics of North America 30: 63–69 (1983).

    PubMed  Google Scholar 

  • Doherty, J.E.: A digoxin-antibiotic drug interaction (Editorial). New England Journal of Medicine 305: 827 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Dravet, C.; Mesdjian, E.; Cenraud, B. and Roger, J.: Interaction between carbamazepine and triacetyloleandomycin. (Correspondence). Lancet 1: 810–811 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Fevery, J.; Van Steenbergen, W.; Desmet, V.; Deruyttere, M. and De Groote, J.: Severe intrahepatic cholestasis due to the combined intake of oral contraceptives and triacetyloleandomycin. Acta Clinica Belgica 38: 242–245 (1983).

    PubMed  CAS  Google Scholar 

  • Fox, J.L.: Infectious asthma treated with triacetyloleandomycin. Pennsylvania Medical Journal 64: 634–635 (1961).

    CAS  Google Scholar 

  • Franco, A.; Boulard, P.; Massot, C.; Lecoeur, J.; Guidicelli, H. and Bessard, G.: Ergotamine par association dihydroergotamine-triacetyloleandomycin. (Correspondence). Nouvelle Presse Medicale 7: 205 (1978).

    PubMed  CAS  Google Scholar 

  • Fraser, D.G.: Selection of an oral erythromycin product. American Journal of Hospital Pharmacy 37: 1199–1205 (1980).

    PubMed  CAS  Google Scholar 

  • Frick, P.G.; Riedler, G. and Brogli, H.: Dose response and minimal daily requirement of vitamin K in man. Journal of Applied Physiology 23: 387–389 (1967).

    PubMed  CAS  Google Scholar 

  • Friedman, H.W. and Bonventre, M.V.: Erythromycin induced digoxin toxicity. (Correspondence). Chest 82: 202 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Gazzaniga, A.B. and Stewart, D.R.: Possible quinidine-induced hemorrhage in a patient on warfarin sodium. New England Journal of Medicine 280: 711–712 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Green, J.A. and Clementi, W.A.: Decrease in theophylline clearance after the administration of erythromycin to a patient with obstructive lung disease. Drug Intelligence and Clinical Pharmacy 17: 370–372 (1983).

    PubMed  CAS  Google Scholar 

  • Gribble, M.J. and Chow, A.W.: Erythromycin. Medical Clinics of North America 66: 79–89 (1982).

    PubMed  CAS  Google Scholar 

  • Haber, I. and Hubens, H.: Cholestatic jaundice after triacetylol-eandomycin and oral contraceptives. The diagnostic value of gamma-glutamyl transpeptidase. Acta Gastroenterolica Belgica 43: 475–482 (1980).

    CAS  Google Scholar 

  • Hayton, A.: Precipitation of acute ergotism by triacetyloleandomycin. (Correspondence). New Zealand Medical Journal 69: 42 (1969).

    PubMed  CAS  Google Scholar 

  • Hemsworth, T.C. and Renton, K.W.: Depression of theophylline metabolism and elimination by troleandomycin and erythromycin. Briochemical Pharmacology 30: 1299–1304 (1981).

    Article  CAS  Google Scholar 

  • Hildebrandt, R.; Gundert-Remy, U.; Möller, H. and Weber, E.: Lack of clinically important interaction between erythromycin and theophylline. European Journal of Clinical Pharmacology 26: 485–489 (1984).

    Article  PubMed  CAS  Google Scholar 

  • Husserl, F.E.: Erythromycin-warfarin interaction. (Correspondence). Archives of Internal Medicine 143: 1831–1836 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Iliopoulou, A.; Aldhous, M.E.; Johnston, A. and Turner, P.: Pharmacokinetic interaction between theophylline and erylhromycin. British Journal of Clincial Pharmacology 14: 495–499 (1982).

    Article  CAS  Google Scholar 

  • Itkin, I.H. and Menzel, M.L.: The use of macrolide antibiotic substances in the treatment of asthma. Journal of Allergy 45: 146–162 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Jonkman, J.H.G.; Hendeles, L.; Weinberger, M. and Maddux, M.S.: The theophylline-erythromycin interaction. (Correspondence). Chest 84: 309–312 (1983).

    Article  Google Scholar 

  • Jusko, W.J.; Schentag, J.J.; Clark, J.H.; Gardner, M. and Yurchak, A.M.: Enhanced biotransformation of theophylline in marijuana and tobacco smokers. Clinical Pharmacology and Therapeutics 24: 406–410 (1978).

    CAS  Google Scholar 

  • Kaplan, M.A. and Godin, M.: The use of triacetyloleandomycin in chronic infectious asthma; in Welch and Marti-Ibanez (Eds). Antibiotics Annual 1958–1959, pp. 273–276 (New York Interscience Publishers, New York 1959).

    Google Scholar 

  • Kappas, A.; Anderson, K.E.; Conney, A.H. and Alvares, A.P.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clinical Pharmacology and Therapeutics 20: 643–653 (1977).

    Google Scholar 

  • Koch-Weser, J.: Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy. Annals of Internal Medicine 68: 511–517 (1968).

    PubMed  CAS  Google Scholar 

  • Kimelblatt, B.J. and Slaughter, R.L.: Lack of effect of intravenous erythromycin lactobionate on theophylline clearance. (Correspondence). Journal of Allergy and Clinical Immunology 65: 313–314 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Kozak, P.P.; Cummins, L.H. and Gillman, S.H.: Administration of erythromycin to patients on theophylline. (Correspondence). Journal of Allergy and Clinical Immunology 60: 149–151 (1977).

    Article  PubMed  CAS  Google Scholar 

  • LaForce, C.F.; Miller, M.F. and Chai, H.: Effect of erythromycin on theophylline clearance in asthmatic children. Journal of Pediatrics 99: 153–156 (1981).

    Article  PubMed  CAS  Google Scholar 

  • LaForce, C.F.; Szefler, S.J.; Miller, M.F.; Ebling, W. and Brenner, M.: Inhibition of methylprednisolone elimination in the presence of erythromycin therapy. Journal of Allergy and Clinical Immunology 72: 34–39 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Larrey, D.; Funck-Brentano, C.; Briel, P.; Vitaux, J.; Theodore, C.; Babany, G. and Pessayre, D.: Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochemical Pharmacology 32: 1063–1068 (1983a).

    Article  PubMed  CAS  Google Scholar 

  • Larrey, D.; Tinel, M. and Pessayre, D.: Formation of inactive cytochrome P-450 Fe(11)-metabolite complexes with several erythromycin derivatives but not with josamycin and mide-camycin in rats. Biochemical Pharmacology 32: 1487–1493 (1983b).

    Article  PubMed  CAS  Google Scholar 

  • Lavarenne, J.; Paire, M. and Talon, O.: Influence d’un nouveau macrolide, la midecamycine sur les taux sanguins de theophylline. Therapie 36: 451–456 (1981).

    PubMed  CAS  Google Scholar 

  • Le Dafniet, M.; Pessayre, D.; Le Quernec, L. and Erlinger, S.: Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats. Journal of Pharmacology and Experimental Therapeutics 219: 558–562 (1981).

    PubMed  Google Scholar 

  • Lesko, L.J.: Nonlinear kinetics and theophylline elimination; in Benet et al. (Eds) Pharmacokinetic Basis for Drug Treatment, pp. 321–332 (Raven Press, New York 1984).

    Google Scholar 

  • Lindenbaum, J.; Rund, D.G.; Bulter Jr, V.P.; Tse-Eng, D. and Saha, J.N.: Inactivation of digoxin by the gut flora: Reversal by antibiotic therapy. New England Journal of Medicine 305: 789–794 (1981a).

    Article  PubMed  CAS  Google Scholar 

  • Lindenbaum, J.; Tse-Eng, D.; Bulter Jr, V.P. and Rund, D.G.: Urinary excretion of reduced metabolites of digoxin. American Journal of Medicine 71: 67–74(1981b).

    Article  PubMed  CAS  Google Scholar 

  • Maddux, M.S.; Leeds, N.H.; Organek, H.W.; Hasegawa, G.R. and Bauman, J.L.: The effect of erythromycin on theophylline pharmacokinetics at steady state. Chest 81: 563–565 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Mansuy, D.; Delaforge, M.; Le Provost, E.; Flinois, J.P.; Columelli, S. and Beaune, P.: Induction of cytochrome P-450 in rat liver by the antibiotic troleandomycin: Partial purification and properties of cytochrome P-450-troleandomycin metabolite complexes. Biochemical and Biophysical Research Communications 103: 1201–1208 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Manzo, L.; Gregotti, C.; Richelmi, P.; Di Nucci, A. and Bertie, F.: Effects of phenobarbitone on the distribution metabolism and biliary excretion of erythromycin in rats. Chemotherapy 26: 164–170 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Matthews, N.T. and Havill, J.H.: Ergotism with therapeutic doses of ergotamine tartrate. New Zealand Medical Journal 89: 476–477 (1979).

    PubMed  CAS  Google Scholar 

  • May, D.C.; Jarboe, C.H.; Ellenburg, D.T.; Roe, E.J. and Karibo, J.: The effects of erythromycin on theophylline elimination in normal males. Journal of Clinical Pharmacology 22: 125–130 (1982).

    PubMed  CAS  Google Scholar 

  • McLean, A.J.; McNamara, P.J.; du Souich, P.; Gibaldi, M. and Lalka, D.: Food, splanchic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clinical Pharmacology and Therapeutics 24: 5–10 (1978).

    PubMed  CAS  Google Scholar 

  • Melethil, S.; Dutta, A.; Ryan, P.B.; Pingleton, S.K. and Kelly, S.J.: Steady state urinary excretion of theophylline and its metabolites in the presence of erythromycin. Research Communications in Chemical Pathology and Pharmacology 35: 341–344 (1982).

    PubMed  CAS  Google Scholar 

  • Mesdjian, E.; Dravet, C.; Cenraud, B. and Roger, J.: Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients. Epilepsia 21: 489–496 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Miguet, J.P.; Monange, C.; Vuitton, D.; Allemand, H.; Hirsch, J.P.; Carayon, P. and Gisselbrecht, H.: Ictere cholestatique survenu apres administration de triacetyloleandomycine: Interference avec le contraceptifs oraux?. Dix observations. (Correspondence). Nouvelle Presse Medicale 7: 4304 (1978).

    PubMed  CAS  Google Scholar 

  • Miguet, J.P.; Vuitton, D.; Pessayre, D.; Allemand, H.; Metreau, J.M.; Poupon, R.; Capron, J.P. and Blanc, F.: Jaundice from troleandomycin and oral contraceptives. (Correspondence). Annals of Internal Medicine 92: 434 (1980).

    PubMed  CAS  Google Scholar 

  • Monks, T.J.; Caldwell, J. and Smith, R.L.: Influence of methylxanthine-conlaining foods on theophylline metabolism and kinetics. Clinical Pharmacology and Therapeutics 26: 513–524 (1979).

    PubMed  CAS  Google Scholar 

  • Morelli, H.F. and Melmon, K.L.: Drug interactions; in Melmon and Morelli (Eds) Clinical Pharmacology: Basic Principles in Therapeutics, 2nd edition, pp.585–604 (MacMillan, New York 1978).

    Google Scholar 

  • Murray, M.D. and Brown, B.K.: Theophylline-erythromycin interaction in an infant. Clinical Pharmacy 1: 107–111 (1982).

    PubMed  CAS  Google Scholar 

  • Parrish, R.A.; Haulman, N.J. and Burns, R.M.: Interaction of theophylline with erythromycin base in a patient with seizure activity. Pediatrics 72: 828–830 (1983).

    Google Scholar 

  • Pershing, L.K. and Franklin, M.R.: Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents. Xenobiotica 12: 687–699 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Pessayre, D.; Descatoire, V.; Konstantinova-Mitcheva, M.; Wandscheer, J.C.; Cobert, B.; Level, R.; Benhamou, P.J.; Jaouen, M. and Mansuy, D.: Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450 Biochemical Pharmacology 30: 553–538 (1981a).

    Article  PubMed  CAS  Google Scholar 

  • Pessayre, D.; Descatoire, V.; Tinl, M. and Larrey, D.: Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin. Journal of Pharmacology and Experimental Therapeutics 221: 215–221 1982a).

    CAS  Google Scholar 

  • Pessayre, D.; Larrey, D.; Vitaux, J.; Breil, P.; Belghiti, J. and Benhamou, J.P.: Formation of an inactive cytochrome P-450 Fe(11)-metabolite complex after administration of troleandomycin in humans. Biochemical Pharmacology 31: 1699–1704 (1982b).

    Article  PubMed  CAS  Google Scholar 

  • Pessayre, D.; Konstantinova-Mitcheva, M.; Descatoire, V.; Cobert, B.; Wandscheer, J.C.; Level, R.; Feldmann, G.; Mansuy, D. and Benhamou, J.P.: Hypoactivity of cytochrome P-450 after triacetyloleandomycin administration. Biochemical Pharmacology 30: 559–564 (1981b).

    Article  PubMed  CAS  Google Scholar 

  • Pessayre, D.; Tinel, M.; Larrey, D.; Cobert, B.; Funck-Brentano, C. and Babany, G.: Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 224: 685–691 (1983).

    PubMed  CAS  Google Scholar 

  • Pfeifer, H.J.; Greenblatt, D.J. and Friedman, P.: Effects of three antibiotics on theophylline kinetics. Clinical Pharmacology and Therapeutics 26: 36–40 (1979).

    PubMed  CAS  Google Scholar 

  • Pingleton, S.K.; Kelly, S.J. and Ryan, P.B.: Lack of effect of erythromycin on theophylline serum levels. (Correspondence). Chest 78: 352 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Prandota, J.; Tillement, J.P.; d’Athis, P.; Campos, H. and Barre, J.: Binding of erythromycin base to human plasma proteins. Journal of International Medical Research 8 (Suppl. 2): 1–8 (1980).

    PubMed  CAS  Google Scholar 

  • Prince, R.A.; Wing, D.S.; Weinberger, M.M.; Hendeles, L.S. and Riegelman, S.: Effect of erythromycin on theophylline kinetics. Journal of Allergy and Clinical Immunology 68: 427–431 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Rall, T.W.: Central nervous system stimulants: The xanthines; in Gillman et al. (Eds) The Pharmacological Basis of Therapeutics, 6th ed., pp. 592–607 (Macmillan, New York 1980).

    Google Scholar 

  • Reisz, G.; Pingleton, S.K.; Melethil, S. and Ryan, P.B.: The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis. American Review of Respiratory Diseases 127: 581–584 (1983).

    CAS  Google Scholar 

  • Renton, R.W.; Gray, J.D. and Hall, R.I.: Decreased elimination of theophylline after influenzae vaccination. Canadian Medical Journal 123: 288–290 (1980).

    CAS  Google Scholar 

  • Renton, K.W.; Gray, J.D. and Hung, O.R.: Depression of theophylline elimination by erythromycin. Clinical Pharmacology and Therapeutics 30: 422–426 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Richer, C.; Mathieu, M.; Bah, H.; Thuillex, C.; Duroux, P. and Giudicelli, J.F.: Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction. Influence of erythromycin. Clinical Pharmacology and Therapeutics 31: 579–586 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Rollux, R.; Plottin, F.; Mingat, J. and Bessard, G.: Ictere apres association estroprogestatif-troleandomycine, trois observations. Nouvelle Presse Medicale 8: 1694 (1979).

    PubMed  CAS  Google Scholar 

  • Ruff, F.; Santais, M.C.; Chastagnol, D.; Huchon, G. and Durieux, P.: Macrolide et theophylline: Absence d’interaction josamycin-theophylline. Nouvelle Presse Medicale 10: 175 (1981).

    PubMed  CAS  Google Scholar 

  • Spector, S.L.; Katz, F.H. and Farr, R.S.: Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitis. Journal of Allergy and Clinical Immunology 54: 367–379 (1974).

    Article  Google Scholar 

  • Stratton, M.A.: Theophylline-erythromycin base interaction. Case report and kinetic profile. Clinical Pharmacy 2: 183–186 (1983).

    PubMed  CAS  Google Scholar 

  • Straughan, J.: Erythromycin-carbamazepine interaction? (Correspondence). South African Medical Journal 61: 420–421 (1982).

    PubMed  CAS  Google Scholar 

  • Stults, B.M.; Felice-Johnson, J.; Higbee, M.D. and Hardigan, K.: Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease. Southern Medical Journal 76: 714–718 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Szefler, S.J.; Brenner, M.; Jusko, W.J.; Spector, S.L.; Flesher, K.A. and Ellis, E.F.: Dose- and time-related effect of troleandomycin on methylprednisolone elimination. Clinical Pharmacology and Therapeutics 32: 166–171 (1982a).

    Article  PubMed  CAS  Google Scholar 

  • Szefler, S.J.; Ellis, E.F.; Brenner, M.; Rose, J.Q.; Spector, S.L.; Yurchak, A.M.; Andrews, F. and Jusko, W.J.: Steroid-specific and anticonvulsant interaction aspects of troleandomycinsteroid therapy. Journal of Allergy and Clinical Immunology 69: 455–460 (1982b).

    Article  PubMed  CAS  Google Scholar 

  • Szefler, S.J.; Rose, J.Q.; Ellis, E.F.; Spector, S.L.; Green, A.W. and Jusko, W.J.: The effect of troleandomycin on methylprednisolone elimination. Journal of Allergy and Clinical Immunology 66: 447–451 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Tang-Liu, D.D.; Williams, R.L. and Riegelman, S.: Nonlinear theophylline elimination. Clinical Pharmacology and Therapeutics 31: 358–369 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Tardrew, P.L.; Mao, J.C.H. and Kenney, D.: Antibacterial activity of 2′-esters of erythromycin. Applied Microbiology 18: 159–165 (1969).

    PubMed  CAS  Google Scholar 

  • Upton, R.A.; Thiercelin, J.-F.; Moore, J.K. and Riegelman, S.: A method for estimating within-individual variability in clearance and in volume ot distribution from standard bioavailability studies. Journal of Pharmacokinetics and Biopharmaceutics 10: 135–146 (1982).

    PubMed  CAS  Google Scholar 

  • Weinberger, M.: Interaction between erythromycin and theophylline. (Correspondence). Pediatrics 61: 324–325 (1978a).

    PubMed  CAS  Google Scholar 

  • Weinberger, M.: TAO and theophylline. (Correspondence). Hospital Practice 13: 22 (1978b).

    PubMed  CAS  Google Scholar 

  • Weinberger, M.; Hudgel, D.; Spector. S. and Chidsey, C.: Inhibition of theophylline clearance by troleandomycin. Journal of Allergy and Clinical Immunology 59: 228–231 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Welling, P.G.: Influence of food and diet on gastrointestinal drug absorption: A review. Journal of Pharmacokinetics and Biopharmaceutics 5: 291–334 (1977).

    PubMed  CAS  Google Scholar 

  • Wilkinson, G.R. and Shand, D.G.: A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).

    PubMed  CAS  Google Scholar 

  • Wong. Y.Y.; Ludden, T.M. and Bell, R.D.: Effect of erythromycin on carbamazepine kinetics. Clinical Pharmacology and Therapeutics 33: 460–464 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Zarowitz. B.J.; Szefler, S.J. and Lasezkay, G.M.: Effect of erythromycin base on theophylline kinetics. Clinical Pharmacology and Therapeutics 29: 601–605 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, The University of Texas at Austin, and Division of Clinical Pharmacology, Department of Pharmacology, The University of Texas Health Science Center, San Antonio, USA

    Thomas M. Ludden

Authors
  1. Thomas M. Ludden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludden, T.M. Pharmacokinetic Interactions of the Macrolide Antibiotics. Clin Pharmacokinet 10, 63–79 (1985). https://doi.org/10.2165/00003088-198510010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198510010-00003

Keywords

Search

Navigation